Navigation Links


VIVUS in Medical News

VIVUS' Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes

...ment in cardiovascular risk factors. About vivus vivus is a biopharmaceutical company developing innovati...of type 2 diabetes. In the area of sexual health, vivus is in phase 3 development with avanafil, a potenti...
VIVUS in Medical Technology

VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction

...l, in males with erectile dysfunction (ED). vivus also announced today that it has completed enrollm...several upcoming medical meetings." About vivus vivus is a biopharmaceutical company developing innovati...

Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity

...ious adverse events reported to date. About vivus vivus is a biopharmaceutical company developing innovati...of type 2 diabetes. In the area of sexual health, vivus is in phase 3 development with avanafil, its PDE5 ...

VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions

...atment of obesity and related conditions. In 2001, vivus in-licensed Dr. Najarian's invention and intellect...t sales. In May of 2006, Dr. Najarian was hired by vivus as part-time Principal Scientist. VIVUS is current...fic Sessions abstract book was not based on Qnexa. vivus provided funding for Dr. Najarian's analysis. Ab...
VIVUS in Biological Technology

VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference

...l Global Growth Conference in Boston. The vivus presentation will take place at the Intercontinent...s or http://www.vivus.com . About vivus vivus is a biopharmaceutical company developing innovati...

VIVUS to Present at the Needham and Company Life Sciences Conference

...nnual Needham Life Sciences Conference. The vivus presentation will take place at the New York Palac...us/ or http://www.vivus.com . About vivus vivus is a biopharmaceutical company developing innovati...

Data on VIVUS' Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting

... Presenter: W. Timothy Garvey, MD About vivus vivus is a biopharmaceutical company developing innovati...of type 2 diabetes. In the area of sexual health, vivus is in phase 3 development with avanafil, a potenti...

VIVUS Reports First Quarter 2009 Financial Results and Highlights

...s and Available for Sale Securities vivus had cash, cash equivalents and available-for-sale ...ceived in the first quarter of 2009. About vivus vivus is a biopharmaceutical company developing innovati...
Other TagsopposeGestGestGestGestGestGestGest
(Date:11/9/2009)...l Nutrition announced today the acquisition of App...ed subsidiary of Natural Nutrition. Natural Nutri... the company will focus its efforts on the busines...oping mobile application market places throughout ...sed on multi platform apps designed to run on devi...
(Date:11/9/2009)...-Asia/ -- Simcere Pharmaceutical Group,(NYSE: SCR...eutical company,specializing in the development, m... proprietary pharmaceuticals in China, today annou...ense in China of Rosuvastatin from Tianjin,Tianda ...on of the,manufacturing license will be effected t...
(Date:11/9/2009)...eer development of scientists and science trainees...inical medicine, AAAS, Science Careers, and Scienc...e called CTSciNet, the Clinical and Translational ...B) November 6, 2009 -- Launched October 20 by Scie... CTSciNet is an online community for people purs...
(Date:11/9/2009)... now available in New York City by pain management...Y (PRWEB) November 9, 2009 -- Davis Bregman , a p...ouse calls to residents of Manhattan in New York C...l by calling the office at 212-918-1629 or sendin...e of being able to see the doctor in the less stre...
(Date:11/9/2009)...form Bill, The Affordable Health Care for American...aturday Night, and Is Expected to Be Signed into L...ith Absolute Confidence. ERISAclaim.com Announced ...cifically for the Compliance with the New Federal ... Hanover Park, IL (PRWEB) November 9, ...
Breaking Medicine News(10 mins):Health News:Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin 2Health News:Social Network for Translational Scientists Launched 2Health News:Social Network for Translational Scientists Launched 3Health News:Social Network for Translational Scientists Launched 4Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 2Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 3Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 4Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 5
(Date:11/8/2009)... Ind. - Researchers at Purdue University have disc...fibers in spinal cord injuries using nano-spheres ...r an accident. , The synthetic "copolymer micell...in diameter, or roughly 100 times smaller than the...e been studying how to deliver drugs for cancer tr...
(Date:11/6/2009)...50th anniversary this month of the publication of ...f Biological Sciences (AIBS) is publishing open ac...in and his historic insights into evolution. , Th...ty of California, Berkeley, and James T. Costa of ...n Myths About Charles Darwin," appeared in the Oct...
(Date:11/5/2009)...iation of Biology Teachers (NABT) will recognize L...ces at Naugatuck Valley Community College (NVCC) i...Education Award during the NABT annual professiona... 2009 in Denver, Colorado. , The Evolution Educa...e of Biological Sciences,(AIBS) and Biological Sc...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Biologists, educators recognize excellence in evolution education 2Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred 4865 1Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred 4865 2Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred 4865 3The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 1The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 2The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 3The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 4The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 5Laureate Pharma Elects New Board Member 13606 1Laureate Pharma Elects New Board Member 13606 2
Other Contentscellularcellularcellularcellularcellularcellularcellularcellularcellularcentriolecentriolecellulosecellulosecellulosecellulosecellulosecellulosecentromerecentromerechemiosmoticcentrosomecentrosomecentrosomesquaresquaresquaresquaresquaresquaresquarechi